Greater impact from programs like 340B and site-neutrality, as well as, an emphasis on the economies of scale and economies of intelligence, can assist community oncology practices in delivering high-quality care, said Tracy Bahl, MBA, president and chief executive officer of OneOncology.
Greater impact from programs like 340B and site-neutrality, as well as, an emphasis on the economies of scale and economies of intelligence, can assist community oncology practices in delivering high-quality care, said Tracy Bahl, MBA, president and chief executive officer of OneOncology.
Transcript
With more patients being treated in the community setting, how are partnerships like OneOncology of growing importance?
Partnerships, whether it’s with OneOncology or anyone who professes to do stuff like we do, are increasingly more important for the future of community oncology. The economies of scale and economies of intelligence necessary to treat patients in the community setting in the future is so very critical, and models like OneOncology deliver that. The economies of scale to drive greater cost efficiencies and improve the cost effectiveness and affordability of patients, as well as, the economies of intelligence which drive real information, real analytics, and real insights that help us advance the science and the care for cancer, are really critical going forward.
What are some recent policy changes that have impacted community practices, and how are practices maneuvering these changes?
There are policy and regulatory changes primarily at the local level that continue to stand in the way of great patient care from time to time, but maybe what’s even most important is the regulatory and policy changes that haven’t happened. There are real improvements necessary to bring balance and perspective to community oncology. Things like 340B [drug pricing program] and site-neutrality, which really haven’t had the kind of action they deserve, would begin to bring better affordability and greater effectiveness for community oncology in the marketplace today.
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More